← The SEC Ephemeris: the whole map
Teva Neuroscience, Inc. risperidone
In the graph: all 1 documents (4 pages).
- Application
- NDA 213586
- Ticker
- Teva Neuroscience, Inc.
- Product
- risperidone
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- April 15, 2022
From FDA letters and SEC filings. Not investment or medical advice.